Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

GSK squares up to Merck with shingles vaccine data

Trial shows vaccine cut the risk of shingles in over 50s by 97%

- PMLiVE

Orexigen’s obesity pill Mysimba set for European approval

But sales of the treatment are only predicted to reach $200m by 2016

- PMLiVE

‘Major step forward’ as EMA recommends first stem cell therapy

But wants more clinical trial data to shore up orphan drug's marketing licence

Lannett appoints Teva’s Michael Bogda as president

He served as VP of technical operations in for Teva’s Americas division

- PMLiVE

Making success measurable

Companies cannot overlook effective evaluation

- PMLiVE

Blue Latitude boosts its team

Appointments follow new business wins for the company

- PMLiVE

NICE backs three ulcerative colitis treatments

Remicade, Simponi and Humira recommended for NHS reimbursement

- PMLiVE

Double trial disappointment for Roche

Discontinues Alzheimer’s programme and finds Kadcyla no better than Herceptin in certain breast cancer

- PMLiVE

Merck stumps up $375m for cancer firm OncoEthix

Follows $8.4bn deal to buy Cubist

- PMLiVE

New medical communications head for S&H

London-based agency appoints Dr Jo Pearson

Pink Carrots appoints art director

Tani Martin joins from Spark44

Creating a 21st century life sciences ecosystem

The UK’s life sciences minister on how government and pharma can encourage NHS uptake and innovation

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links